{
    "2019-09-27": [
        [
            {
                "time": "2018-09-14",
                "original_text": "Mylan Misled Investors Over EpiPen Pricing Probe, SEC Says",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Misled",
                        "EpiPen",
                        "Pricing",
                        "Probe",
                        "SEC"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-15",
                "original_text": "Growth stocks vs. value stocks",
                "features": {
                    "keywords": [
                        "Growth",
                        "stocks",
                        "value"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-16",
                "original_text": "Dow flat despite gains for Walgreens Boots, Pfizer shares",
                "features": {
                    "keywords": [
                        "Dow",
                        "flat",
                        "gains",
                        "Walgreens",
                        "Boots",
                        "Pfizer"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-17",
                "original_text": "Nektar Stock Down on Disappointing Breast Cancer Study Data",
                "features": {
                    "keywords": [
                        "Nektar",
                        "Stock",
                        "Down",
                        "Disappointing",
                        "Breast",
                        "Cancer",
                        "Study",
                        "Data"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-18",
                "original_text": "Dow Jones Today: Stocks Turn Mixed, Consumer Spending Data Weak, Wells Fargo Gets A New CEO",
                "features": {
                    "keywords": [
                        "Dow",
                        "Jones",
                        "Stocks",
                        "Mixed",
                        "Consumer",
                        "Spending",
                        "Data",
                        "Weak",
                        "Wells",
                        "Fargo",
                        "CEO"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-19",
                "original_text": "UPDATE 1-Pfizer veteran Ian Read to retire as executive chairman",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Ian",
                        "Read",
                        "retire",
                        "executive",
                        "chairman"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-20",
                "original_text": "Pfizer Inc. Awards “Golden Tickets” to Neutrolis and Mediar Therapeutics",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Golden",
                        "Tickets",
                        "Neutrolis",
                        "Mediar",
                        "Therapeutics"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-21",
                "original_text": "Dow Jones Today: Futures Rise Ahead of Data, Apple Heads For Hollywood",
                "features": {
                    "keywords": [
                        "Dow",
                        "Jones",
                        "Futures",
                        "Rise",
                        "Data",
                        "Apple",
                        "Hollywood"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-22",
                "original_text": "Ian Read to retire as Pfizer executive chairman",
                "features": {
                    "keywords": [
                        "Ian",
                        "Read",
                        "retire",
                        "Pfizer",
                        "executive",
                        "chairman"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-23",
                "original_text": "Ian Read to Retire as Executive Chairman of Pfizer’s Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman",
                "features": {
                    "keywords": [
                        "Ian",
                        "Read",
                        "Retire",
                        "Executive",
                        "Chairman",
                        "Pfizer",
                        "Board",
                        "Directors",
                        "Albert",
                        "Bourla",
                        "Chairman"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-24",
                "original_text": "The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave",
                "features": {
                    "keywords": [
                        "Biotech",
                        "ESMO",
                        "Conference",
                        "J&J",
                        "Darzalex",
                        "Approval",
                        "Kaleido",
                        "Biosciences",
                        "CFO"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-25",
                "original_text": "Pfizer shares up 1.3% premarket after reporting positive results in second trial of dermatitis treatment",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "shares",
                        "up",
                        "premarket",
                        "positive",
                        "results",
                        "dermatitis",
                        "treatment"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-26",
                "original_text": "Pfizer Announces Positive Top-Line Results from Second Pivotal Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib, in Patients Aged 12 and Older with Moderate to Severe Atopic Dermatitis",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Positive",
                        "Top-Line",
                        "Results",
                        "Phase",
                        "3",
                        "Study",
                        "Abrocitinib",
                        "Atopic",
                        "Dermatitis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-27",
                "original_text": "Pfizer Edges Higher After Positive Trials for Moderate-to-Severe Eczema Drug",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Edges",
                        "Higher",
                        "Positive",
                        "Trials",
                        "Moderate-to-Severe",
                        "Eczema",
                        "Drug"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}